The Safest Option in Trades!
If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!
Click here now!
Marcus Schulz, insider at BioLife Solutions

Marcus Schulz Insider Information

Marcus Schulz  started at BioLife in 2020 as Vice President of Global Sales and was promoted to Chief Revenue Officer in 2021. He brings 20 years of healthcare experience to the Biolife executive leadership team.

Prior to joining BioLife in 2019, Marcus served in a variety of strategic business development and executive sales leadership roles with such leading companies as Siemens Healthcare, Johnson & Johnson, Abbott Laboratories and most recently, GE Healthcare. Marcus consistently delivers exceptional results, driving record revenues and growing market share in highly competitive and complex market segments.

He thinks of himself as a customer advocate and takes pride in building strong, lasting relationships through an in-depth understanding of each customer’s unique needs. He excels at identifying and nurturing talent and developing and leading strong teams. Marcus holds a B.A. from Villanova University.

What is Marcus Schulz's net worth?

The estimated net worth of Marcus Schulz is at least $889,567.84 as of August 10th, 2022. Mr. Schulz owns 36,176 shares of BioLife Solutions stock worth more than $889,568 as of August 15th. This net worth approximation does not reflect any other investments that Mr. Schulz may own. Additionally, Mr. Schulz receives a salary of $778,220.00 as CRO at BioLife Solutions. Learn More about Marcus Schulz's net worth.

How old is Marcus Schulz?

Mr. Schulz is currently 43 years old. There are 7 older executives and no younger executives at BioLife Solutions. The oldest executive at BioLife Solutions is Mr. Roderick de Greef, Pres & COO, who is 62 years old. Learn More on Marcus Schulz's age.

What is Marcus Schulz's salary?

As the CRO of BioLife Solutions, Inc., Mr. Schulz earns $778,220.00 per year. The highest earning executive at BioLife Solutions is Mr. Michael P. Rice, Chairman & CEO, who commands a salary of $1,240,000.00 per year. Learn More on Marcus Schulz's salary.

How do I contact Marcus Schulz?

The corporate mailing address for Mr. Schulz and other BioLife Solutions executives is 3303 MONTE VILLA PARKWAY SUITE 310, BOTHELL WA, 98021. BioLife Solutions can also be reached via phone at (425) 402-1400 and via email at [email protected] Learn More on Marcus Schulz's contact information.

Has Marcus Schulz been buying or selling shares of BioLife Solutions?

In the last ninety days, Marcus Schulz has sold $103,705.78 of BioLife Solutions stock. Most recently, Marcus Schulz sold 42 shares of the business's stock in a transaction on Wednesday, August 10th. The shares were sold at an average price of $23.17, for a transaction totalling $973.14. Following the completion of the sale, the executive now directly owns 36,176 shares of the company's stock, valued at $838,197.92. Learn More on Marcus Schulz's trading history.

Who are BioLife Solutions' active insiders?

BioLife Solutions' insider roster includes Sarah Aebersold (VP), Todd Berard (CMO), Roderick de Greef (CFO), Karen Foster (Insider), Andrew Hinson (Director), Aby Mathew (VP), Michael Rice (CEO), Joseph Schick (Director), Marcus Schulz (CRO), and Troy Wichterman (CFO). Learn More on BioLife Solutions' active insiders.

Are insiders buying or selling shares of BioLife Solutions?

In the last twelve months, insiders at the medical equipment provider sold shares 124 times. They sold a total of 648,085 shares worth more than $23,090,235.80. The most recent insider tranaction occured on August, 10th when EVP Aby J Mathew sold 112 shares worth more than $2,595.04. Insiders at BioLife Solutions own 3.3 % of the company. Learn More about insider trades at BioLife Solutions.

Information on this page was last updated on 8/10/2022.

Marcus Schulz Insider Trading History at BioLife Solutions

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/10/2022Sell42$23.17$973.1436,176View SEC Filing Icon  
8/3/2022Sell4,600$20.03$92,138.0036,218View SEC Filing Icon  
7/22/2022Sell367$17.94$6,583.9840,818View SEC Filing Icon  
7/12/2022Sell254$15.79$4,010.6641,185View SEC Filing Icon  
5/13/2022Sell41$12.32$505.1241,439View SEC Filing Icon  
4/21/2022Sell477$13.94$6,649.3841,480View SEC Filing Icon  
4/18/2022Sell286$17.59$5,030.7441,957View SEC Filing Icon  
2/10/2022Sell167$29.38$4,906.46View SEC Filing Icon  
1/20/2022Sell395$30.24$11,944.80View SEC Filing Icon  
1/12/2022Sell267$32.18$8,592.06View SEC Filing Icon  
11/9/2021Sell1,750$53.00$92,750.00View SEC Filing Icon  
10/20/2021Sell399$42.34$16,893.66View SEC Filing Icon  
10/11/2021Sell245$38.22$9,363.90View SEC Filing Icon  
7/26/2021Sell4,919$45.65$224,552.35View SEC Filing Icon  
7/20/2021Sell2,539$45.10$114,508.9036,366View SEC Filing Icon  
7/8/2021Sell240$45.73$10,975.20View SEC Filing Icon  
4/20/2021Sell650$32.10$20,865.0039,145View SEC Filing Icon  
4/8/2021Sell224$35.77$8,012.4839,795View SEC Filing Icon  
1/12/2021Sell2,000$41.01$82,020.0037,107View SEC Filing Icon  
1/8/2021Sell293$39.01$11,429.9339,107View SEC Filing Icon  
11/12/2020Sell1,400$32.51$45,514.0039,400View SEC Filing Icon  
10/12/2020Sell953$28.20$26,874.6041,753View SEC Filing Icon  
See Full Table

Marcus Schulz Buying and Selling Activity at BioLife Solutions

This chart shows Marcus Schulz's buying and selling at BioLife Solutions by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

BioLife Solutions Company Overview

BioLife Solutions logo
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; and the ThawSTAR line that includes automated vial and cryobag thawing products that control the heat and timing of the thawing process of biologic materials. The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage services. It markets and sells its products directly, as well as through third party distributors. BioLife Solutions, Inc. was incorporated in 1987 and is headquartered in Bothell, Washington.
Read More

Today's Range

Now: $26.01
Low: $24.39
High: $26.13

50 Day Range

MA: $16.82
Low: $12.99
High: $24.59

2 Week Range

Now: $26.01
Low: $10.40
High: $60.67

Volume

361,021 shs

Average Volume

418,607 shs

Market Capitalization

$1.11 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.99
A One Stop Shop for Everything Futures Trading
Whether you're looking to learn the basics of futures or are a seasoned vet looking to hone your trading skills, our Technical Analysis Guide has everything you need to succeed in today's futures markets!
Download your FREE Technical Analysis Trading Guide Today.